FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, and concerns a pharmaceutical composition for the therapy of acute toxic conditions. The composition for the therapy of acute toxic conditions contains a protein - human lactoferrin, and additionally contains non-replicating nanoparticles with an inserted gene of human lactoferrin, and an expressing buffer in the following proportions per a dose: human lactoferrin 50 to 100 mg; non-replicating nanoparticles - 7×1011 of physical particles; the expressing buffer - the rest, ml. Human lactoferrin is either donor breast milk lactoferrin, or any human lactoferrin.
EFFECT: invention provides fast onset and prolonged antitoxic action.
4 cl, 8 ex, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION PRODUCING ANTIOXIDANT, ANTIMICROBIAL, ANTITOXIC HUMAN LACTOFERRIN PROTEIN, METHOD FOR PREPARING IT, AND METHOD OF THERAPY | 2012 |
|
RU2489168C1 |
PHARMACEUTICAL COMPOSITION AND METHOD OF THERAPY OF NEURODEGENERATIVE DISORDERS, INCLUDING AMYOTROPHIC LATERAL SCLEROSIS | 2012 |
|
RU2491097C1 |
METHOD FOR TREATING POSTOPERATIVE COMPLICATIONS | 2001 |
|
RU2199337C1 |
RECOMBINANT TRIVALENT INFLUENZA VACCINE | 2012 |
|
RU2485973C1 |
BALANCED INFUSION SOLUTION | 2014 |
|
RU2549448C1 |
TREATMENT METHOD FOR AMYOTROPHIC LATERAL SCLEROSIS | 2023 |
|
RU2804196C1 |
AGENT FOR PROPHYLAXIS DISEASES OF ONCOLOGICAL AND NON-ONCOLOGICAL PATTERN AND FOR CORRECTION OF HOMEOSTASIS DISTURBANCES | 2001 |
|
RU2208446C2 |
PREPARATION ELICITING HEPATOPROTECTIVE EFFECT | 2001 |
|
RU2186577C1 |
METHOD FOR OBTAINING A VEGETABLE ML1 LECTURE FROM A MISSILE WHITE AND A PHARMACEUTICAL COMPOSITION ON ITS BASIS (VARIANTS) | 2016 |
|
RU2644332C1 |
USE OF POLYDATINE FOR TREATING HEPATIC DISEASES AND POLYDATINE PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2468803C2 |
Authors
Dates
2013-07-27—Published
2012-02-16—Filed